Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 1Sleep Initiation and Maintenance Disorders 1Neoplasms 1Melanoma 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Depression 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

morphine, naltrexone combination 1Tapentadol 1Naltrexone 1Morphine 1Cognitive Behavioral Therapy 16'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Chronic Pain × Cognitive Behavioral Therapy × Clear all
NCT02132221 2019-03-08

Cessation of Long-term Opioid Therapy in Chronic Pain Patients

Massachusetts General Hospital

Phase NA Terminated
6 enrolled

Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡